TRMED — Thor Medical ASA Cashflow Statement
0.000.00%
Last trade - 00:00
- NOK240.55m
- NOK198.78m
- 11
- 51
- 41
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -433 | -416 | -440 | -310 | -5.56 |
Depreciation | |||||
Non-Cash Items | 4.52 | -28.1 | 4.38 | -11.7 | -28.2 |
Discontinued Operations | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4.86 | 31.2 | 20.9 | -98.2 | -31.1 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -411 | -398 | -403 | -409 | -64.1 |
Capital Expenditures | -1.07 | -0.185 | -0.259 | -5.63 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 5.61 | 1.59 | 1.12 | 3.16 | 6.28 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 4.54 | 1.41 | 0.863 | -2.46 | 6.28 |
Financing Cash Flow Items | -39.1 | -16.3 | -28 | -17.2 | -0.32 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 435 | 201 | 385 | 228 | -0.332 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 30.8 | -177 | -16.3 | -179 | -56.9 |